OptimizeRx (OPRX) Retained Earnings (2010 - 2026)

OptimizeRx has disclosed Retained Earnings across 17 years of filings, most recently posting $211.5 million for Q2 2026.

• In Q2 2026, Retained Earnings rose 3.52% year-over-year to $211.5 million; the TTM figure through Jun 2026 stood at $211.5 million (up 3.52% YoY), while the FY2025 annual figure was $207.5 million, up 3.06% from the prior year.
• Retained Earnings came in at $211.5 million for Q2 2026 at OptimizeRx, up from $209.3 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $211.5 million in Q2 2026 to a low of $170.0 million in Q1 2022.
• Average Retained Earnings over 5 years is $191.7 million, with a median of $194.9 million recorded in 2024.
• Year-over-year, Retained Earnings increased 14.4% in 2022 and retreated 5.8% in 2023.
• Over 5 years, Retained Earnings stood at $172.8 million in 2022, then grew by 10.42% to $190.8 million in 2023, then gained by 5.53% to $201.3 million in 2024, then grew by 3.06% to $207.5 million in 2025, then gained by 1.92% to $211.5 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $211.5 million in Q2 2026, $209.3 million in Q1 2026, and $207.5 million in Q4 2025.